Biologická léčba XIX
Části
Zobrazit detail | ||||
---|---|---|---|---|
N006/20/V00030586/001 | I. Trastuzumab (ATC L01XC03) | Antineoplastika | Zadán | |
N006/20/V00030586/002 | II. Trastuzumab emtansin (ATC L01XC14) | Antineoplastika | Zadán | |
N006/20/V00030586/003 | III. Pertuzumab (ATC L01XC13) | Antineoplastika | Zadán | |
N006/20/V00030586/004 | IV. Vismodegib (ATC L01XX43) | Antineoplastika | Zadán | |
N006/20/V00030586/005 | V. Vemurafenib (ATC L01XE15) | Antineoplastika | Zadán | |
N006/20/V00030586/006 | VI. Pirfenidon (ATC L04AX05) | Imunosupresiva | Zadán | |
N006/20/V00030586/007 | VII. Okrelizumab (ATC L04AA36) | Imunosupresiva | Zadán |